The need to improve the efficiency and quality of X-ray examinations will drive healthcare facilities across Europe to install computed radiography (CR) and digital radiography (DR) systems. The emergence of retrofit systems based on flat panel technology has popularised DR systems, and will sustain more
Frost & Sullivan
News Frost & Sullivan
-
Emphasis on X-ray quality spurs adoption of radiography, finds Frost & Sullivan
-
Frost & Sullivan determines a real and urgent need for novel cancer diagnostics tests
The range of potential therapeutic approaches available to treat cancer is expected to expand rapidly during the next decade. Current diagnostic technologies focus on detection and diagnosis of cancer using mainly blood, faeces, urine tests or genetic tests. Testing methods are now gradually moving more
-
Frost & Sullivan: Automation will represent the next step for biobanks
Every year, nearly 100 million samples are added to biobanks worldwide. Over 1500 bio repositories exist today and efforts are underway to automate the various sample handling and compound storage processes involved in biobanking. The increased focus on preservation of sample integrity and biobankin more
Websites Frost & Sullivan
ESBATech AG
The Company Products & Technologies PR and Publications Career About ESBATech People Intellectual Property Directions Contact Drug Discovery Drug Development Company News Scientific Publications Upcoming Events PR Contact Why ESBATech Positions To apply Webmail ESBATech, an Alcon Biomedical Resear more
Environmental LIMS | Public Health LIMS | Water Quality LIMS | Clinical LIMS from ChemWare
RECOGNITION ABOUT CHEMWARE CONTACT US PARTNERS AND AFFILIATIONS CAREERS GUARANTEES PRINTER FRIENDLY - Software Quality Leadership - 2009 Fast 50 Award | 2008 Excellence in Innovation Award Top PHL Survey Ranking | Application Security Certification | Technology Quality Award - ChemWare Named more
ESBATech AG
The Company Products & Technologies PR and Publications Career Company News HUENENBERG and ZURICH, Switzerland – September 14, 2009 Alcon to Acquire Swiss Biotechnology Firm, ESBATech AG Company gains access to proprietary antibody fragment technology particularly suited to treat eye diseases more





